Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Auto and Transport Industry News REV Group to launch bullet-proof REV Guardian ambulance Auto industry news : US specialty vehicles manufacturer REV Group said that its unit REV Ambulance Group will… bySrinathJune 26, 2018
